Skip to main content
Kajaria Ceramics Ltd logo

Kajaria Ceramics Ltd — Investor Relations & Filings

Ticker · KAJARIACER ISIN · INE217B01036 LEI · 3358007XN6AXJ1V67M07 BSE.NS Manufacturing
Filings indexed 1,662 across all filing types
Latest filing 2024-05-07 Board/Management Inform…
Country IN India
Listing BSE.NS KAJARIACER

About Kajaria Ceramics Ltd

https://www.kajariaceramics.com/

Kajaria Ceramics Ltd specializes in the production of ceramic and vitrified tiles, maintaining a diverse portfolio that includes ceramic wall and floor tiles, polished vitrified tiles, and glazed vitrified tiles. The company has expanded its offerings to include integrated bathroom solutions such as sanitaryware and faucets, alongside tile adhesives. Operating with advanced manufacturing facilities, the firm emphasizes technical precision and design innovation. Its products cater to both residential and commercial sectors, supported by a robust distribution infrastructure. The company is recognized for its extensive range of textures, patterns, and finishes, focusing on high-quality standards and sustainable production practices to meet global architectural requirements.

Recent filings

Filing Released Lang Actions
Financial Results as on 31st March 2024
Board/Management Information Classification · 95% confidence The document is a detailed announcement from the Board of Directors regarding the outcome of a board meeting. It includes approval of audited financial results for the quarter and year ended March 31, 2024, along with auditors' reports. It also discusses dividend recommendations, investment limit increases in subsidiaries, director appointments, and project approvals. The document references compliance with SEBI Listing Regulations and includes annexures with detailed investment information. The content is primarily about board decisions and disclosures pursuant to regulatory requirements, not the full annual report or standalone audit report. It is not a transcript, earnings release, or capital update. The focus on board meeting outcomes and regulatory disclosures aligns with Board/Management Information filings (MANG). The document length and detail confirm it is not a brief announcement or certification. Therefore, the classification is Board/Management Information (MANG).
2024-05-07 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from the Board of Directors regarding the outcome of a board meeting. It includes approval of audited financial results for the quarter and year ended March 31, 2024, along with auditors' reports. It also covers dividend recommendations, investment limit increases in subsidiaries, director appointments, and project approvals. The document references compliance with SEBI Listing Regulations and includes annexures with detailed investment information. The content is primarily an official announcement of board decisions and financial results approval rather than the full financial report itself. The document length is about 15,000 characters, but it is structured as a formal announcement of board meeting outcomes and related regulatory disclosures, not the full annual report or audit report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure rather than a full Annual Report (10-K) or Audit Report (AR).
2024-05-07 English
Dividend
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from the Board of Directors regarding the outcome of a board meeting. It includes approval of audited financial results for the quarter and year ended March 31, 2024, along with auditors' reports. It also covers dividend recommendations, investment limit increases in subsidiaries, director appointments, and project approvals. The document references compliance with SEBI Listing Regulations and includes annexures with detailed investment information. The content is primarily an official announcement of board decisions and financial results approval rather than the full financial report itself. The document length is about 15,000 characters, which is substantial but the content is structured as a formal announcement letter to stock exchanges rather than a full annual or quarterly report. Therefore, it fits best as a Regulatory Filing (RNS) because it is a regulatory announcement of board meeting outcomes and financial results approval, not the full Annual Report (10-K) or Interim Report (IR).
2024-05-07 English
Dividend
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from the Board of Directors regarding the outcome of a board meeting. It includes approval of audited financial results for the quarter and year ended March 31, 2024, along with auditors' reports. It also covers dividend recommendations, investment limit increases in subsidiaries, director appointments, and project approvals. The document references compliance with SEBI Listing Regulations and includes annexures with detailed investment information. The content is primarily an official announcement of board decisions and financial results approval rather than the full financial report itself. The document length is about 15,000 characters, which is substantial but the content is structured as a formal announcement letter to stock exchanges. This fits best with the category of Regulatory Filings (RNS), as it is a regulatory announcement of board meeting outcomes and financial results, not the full Annual Report (10-K) or standalone Audit Report (AR).
2024-05-07 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from the Board of Directors regarding the outcome of a board meeting. It includes approval of audited financial results for the quarter and year ended March 31, 2024, along with auditors' reports, dividend recommendations, investment limit increases in subsidiaries, and other corporate decisions. The document references compliance with SEBI Listing Regulations and includes annexures with detailed information about investments and director appointments. The content is primarily an official announcement of board meeting outcomes and regulatory disclosures rather than the full audited financial report itself. The document length is about 15,000 characters, which is substantial but the content is focused on announcements and approvals rather than presenting full financial statements or management discussion and analysis. Therefore, this document fits best as a Regulatory Filing (RNS) because it is a formal regulatory announcement of board meeting outcomes and financial results approval, not the full Annual Report or Audit Report itself.
2024-05-07 English
Financial Result Updates
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from the Board of Directors regarding the outcome of a board meeting. It includes approval of audited financial results for the quarter and year ended March 31, 2024, along with auditors' reports. It also discusses dividend recommendations, investment limit increases in subsidiaries, director appointments, and project approvals. The document references compliance with SEBI Listing Regulations and includes annexures with detailed investment information. The content is primarily an official announcement of board decisions and financial results approval rather than the full financial report itself. The document length is about 15,000 characters, which is substantial but the content is structured as a board meeting outcome announcement rather than a full annual or quarterly report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure rather than a full Annual Report (10-K) or Interim Report (IR).
2024-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.